Skip to main content

The obscure advisory committees at the heart of the US drug pricing debate

Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.

from Latest http://bit.ly/2vqvFAH

Comments

Popular posts from this blog

Trump Claims There Is a Crisis at the Border. What’s the Reality?

By JOE WARD and ANJALI SINGHVI via NYT U.S. https://nyti.ms/2RqBfR6